Precision engineered cell mimics for flow cytometry

New synthetic cell-mimic controls enable researchers to achieve reproducible results across multiple sites and instruments

10 Sept 2026
Amsbio precision-engineered cell mimics

Precision-engineered cell mimics

Amsbio has launched a range of synthetic cell mimic products that eliminate the variability, fragility, and operational inefficiency inherent in traditional flow cytometry biological and polystyrene bead controls.

Researchers in pharmaceutical companies, biotechnology firms, CRO’s, clinical diagnostics and academic centers have long sought access to mass-produced cell mimics that contain rare biomarkers and are stable over the long term for the development of targeted therapies.

Benefitting from unmatched lot-to-lot consistency with coefficients of variation as low as 0.1% these new synthetic cell-mimic controls enable researchers to achieve reproducible results across multiple sites and instruments. This consistency is a critical requirement for clinical trials, cell therapy manufacturing, and rapid, successful regulatory submissions.

For laboratory teams running flow cytometry assays across instruments, operators, and sites, Amsbio can now offer cell-mimic controls that deliver biology-like behaviour without donor PBMCs’ variability, biohazardous materials safety burden, or cell lines maintenance overhead. This helps researchers standardize workflows, tighten assay performance, and reduce bridging studies.

Offering extended shelf life with no maintenance required – synthetic cell mimics from Amsbio are fully customizable with biomarkers, proteins, and fluorescence making them perfect for any need.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Flow CytometryClinical TrialsCell TherapyCell therapy involves using living cells to treat diseases, often by replacing damaged cells or stimulating regeneration. Stem cell therapy and CAR-T cell therapy are examples of cutting-edge treatments in regenerative medicine and cancer immunotherapy. Browse our peer-reviewed product directory to find the best cell therapy tools, compare products, check reviews, and get pricing directly from manufacturers.

Frequently asked questions

Show frequently asked questions

What are Amsbio synthetic cell mimics used for in flow cytometry?

Amsbio synthetic cell mimics serve as stable, mass-produced flow cytometry controls. They provide biology-like behavior while eliminating the variability, fragility, biohazard safety burden, and operational inefficiency associated with donor PBMCs, biological controls, polystyrene beads, and maintained cell lines.

How do Amsbio cell-mimic controls improve assay reproducibility?

Amsbio cell-mimic controls offer lot-to-lot consistency with coefficients of variation as low as 0.1%. This enables reproducible flow cytometry results across instruments, operators, and sites, helping laboratories standardize workflows, tighten assay performance, reduce bridging studies, and support clinical trials, cell therapy manufacturing, and regulatory submissions.

Can Amsbio synthetic cell mimics be customized for rare biomarkers?

Yes. Amsbio synthetic cell mimics are fully customizable with biomarkers, proteins, and fluorescence, including rare biomarkers needed for targeted therapy development. They also offer an extended shelf life and require no maintenance, making them suitable for pharmaceutical companies, biotechnology firms, CROs, clinical diagnostics laboratories, and academic centers.